# José Alexandre S. Crippa

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jose-alexandre-s-crippa/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,102 |
| Field | Cannabis and Cannabinoid Research |
| h-index | 64 |
| i10-index | 205 |
| Last Known Institution | Conselho Nacional de Desenvolvimento Científico e Tecnológico |
| OpenAlex ID | https://openalex.org/A5054036019 |
| ORCID iD | 0000-0001-9520-6746 |
| Works | 381 |

## Researcher papers

- [Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology](https://scholariq.org/papers/opposite-effects-of-9-tetrahydrocannabinol-and-cannabidiol-on-human-brain/)
- [Alcohol Use Disorders Identification Test (AUDIT): An updated systematic review of psychometric properties.](https://scholariq.org/papers/alcohol-use-disorders-identification-test-audit-an-updated-systematic-review-of/)
- [Cannabis and anxiety: a critical review of the evidence](https://scholariq.org/papers/cannabis-and-anxiety-a-critical-review-of-the-evidence/)
- [Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report](https://scholariq.org/papers/antidepressant-effects-of-a-single-dose-of-ayahuasca-in-patients-with-recurrent/)
- [Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression](https://scholariq.org/papers/antidepressant-effects-of-a-single-dose-of-ayahuasca-in-patients-with-recurrent-2/)
- [Confiabilidade da "Entrevista Clínica Estruturada para o DSM-IV - Versão Clínica" traduzida para o português](https://scholariq.org/papers/confiabilidade-da-entrevista-clinica-estruturada-para-o-dsm-iv-versao-clinica/)
- [Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial](https://scholariq.org/papers/effects-of-cannabidiol-in-the-treatment-of-patients-with-parkinson-s-disease-an/)
- [Clinical validity and intrarater and test–retest reliability of the Structured Clinical Interview for DSM‐5 – Clinician Version (SCID‐5‐CV)](https://scholariq.org/papers/clinical-validity-and-intrarater-and-test-retest-reliability-of-the-structured/)
- [Study of the Discriminative Validity of the PHQ-9 and PHQ-2 in a Sample of Brazilian Women in the Context of Primary Health Care](https://scholariq.org/papers/study-of-the-discriminative-validity-of-the-phq-9-and-phq-2-in-a-sample-of/)
- [Effects of Cannabidiol (CBD) on Regional Cerebral Blood Flow](https://scholariq.org/papers/effects-of-cannabidiol-cbd-on-regional-cerebral-blood-flow/)
- [Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?](https://scholariq.org/papers/is-cannabidiol-during-neurodevelopment-a-promising-therapy-for-schizophrenia-and/)

## Researcher topics

- [Cannabis and Cannabinoid Research](https://scholariq.org/topics/cannabis-and-cannabinoid-research/)
- [Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes](https://scholariq.org/topics/anxiety-depression-psychometrics-treatment-cognitive-processes/)
- [Psychedelics and Drug Studies](https://scholariq.org/topics/psychedelics-and-drug-studies/)
- [Neurotransmitter Receptor Influence on Behavior](https://scholariq.org/topics/neurotransmitter-receptor-influence-on-behavior/)
- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)

## Researcher university

- [Conselho Nacional de Desenvolvimento Científico e Tecnológico](https://scholariq.org/institutions/conselho-nacional-de-desenvolvimento-cientifico-e-tecnologico/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.